Stockholm, 2013-10-15 08:30 CEST (GLOBE NEWSWIRE) -- DSMB has analyzed the test results from the sixth patient, which was enrolled in the study two weeks ago. The study is now in the final phase of the first part, the so-called dose-escalation part. With the approval to proceed with the study, the sixth and last patient can continue to receive the second cycle of the higher dose of PledOx.
Help employers find you! Check out all the jobs and post your resume.
